BLTE is expected to report earnings to rise+25% to -30 cents per share on March 12

A.I.dvisor
at Tickeron.com
03/11/24
Loading...
BLTE - Belite Bio
Belite Bio Earnings Graph
Q4'23
Est.
$-0.30
Q3'23
Missed
by $0.08
Q2'23
Missed
by $0.03
Q1'23
Missed
by $0.13
Q4'22
Missed
by $0.25
The last earnings report on September 30 showed earnings per share of -40 cents, missing the estimate of -32 cents. P/B Ratio (24.096) is normal, around the industry mean (29.167). P/E Ratio (0.000) is within average values for comparable stocks, (124.457). BLTE's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.197). Dividend Yield (0.000) settles around the average of (0.030) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (436.179). With 42.52K shares outstanding, the current market capitalization sits at 1.27B.
View a ticker or compare two or three
BLTEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
12750 High Bluff Drive
Phone
+1 858 246-6240
Employees
20
Web
https://www.belitebio.com